{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:54:02Z","timestamp":1792220042552,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s10549-004-6590-0","type":"journal-article","created":{"date-parts":[[2004,11,5]],"date-time":"2004-11-05T04:30:55Z","timestamp":1099629055000},"page":"205-214","source":"Crossref","is-referenced-by-count":64,"title":["Expression of sigma 1 receptor in human breast cancer"],"prefix":"10.1007","volume":"87","author":[{"given":"B.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. T.","family":"Albarracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Meric","family":"Bernstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Marcelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","volume":"93","author":"M Hanner","year":"1996","unstructured":"Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H:Purication, molecular cloning,and expression of the mammalian sigma1-binding site.Proc Natl Acad Sci USA 93:8072?8077,1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)01723-0","volume":"469","author":"RR Matsumoto","year":"2003","unstructured":"Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ: Sigma receptors:potential medications development target for anti-cocaine agents.Eur J Pharmacol 469:1?12,2003","journal-title":"Eur J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-6147(92)90030-A","volume":"13","author":"R Quirion","year":"1992","unstructured":"Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, Taylor DP:A proposal for the classi cation of sigma binding sites.Trends Phar-macol Sci 13:85?86,1992","journal-title":"Trends Phar-macol Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1073\/pnas.92.9.3774","volume":"92","author":"FP Monnet","year":"1995","unstructured":"Monnet FP, Mahe V, Robel P, Baulieu EE:Neurosteroids, via sigma receptors,modulate the [3H ]norepinephrine release evoked by N-methyl-D D-aspartate in the rat hippo-campus.Proc Natl Acad Sci USA 92:3774?3778,1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","first-page":"1269","volume":"298","author":"A Urani","year":"2001","unstructured":"Urani A, Roman FJ, Phan VL, Su TP, Maurice T:The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test.J Pharmacol Exp Ther 298:1269?1279,2001","journal-title":"J Pharmacol Exp Ther"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1471-4159.1998.70030922.x","volume":"70","author":"P Seth","year":"1998","unstructured":"Seth P, Fei YJ, Li HW, Huang W, Leibach FH, Ganapathy V:Cloning and functional characterization of a sigma receptor from rat brain.J Neurochem 70:922?931,1998","journal-title":"J Neurochem"},{"key":"CR7","first-page":"408","volume":"55","author":"BJ Vilner","year":"1995","unstructured":"Vilner BJ, John CS, Bowen WD:Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.Cancer Res 55:408?413,1995","journal-title":"Cancer Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"18387","DOI":"10.1074\/jbc.274.26.18387","volume":"274","author":"RA Wilke","year":"1999","unstructured":"Wilke RA, Mehta RP, Lupardus PJ, Chen Y, Ruoho AE, Jackson MB:Sigma receptor photolabeling and sigma receptor-mediated modulation of potassium channels in tumor cells.J Biol Chem 274:18387?18392,1999","journal-title":"J Biol Chem"},{"key":"CR9","first-page":"1300","volume":"269","author":"C Ela","year":"1994","unstructured":"Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y:Sigma receptor ligands modulate contractility,Ca++in.ux and beating rate in cultured cardiac myocytes.J Pharmacol Exp Ther 269:1300?1309,1994","journal-title":"J Pharmacol Exp Ther"},{"key":"CR10","first-page":"788","volume":"293","author":"T Hayashi","year":"2000","unstructured":"Hayashi T, Maurice T, Su TP:Ca(2+)signaling via sigma(1)-receptors:novel regulatory mechanism affecting intracellular Ca(2+)concentration.J Pharmacol Exp Ther 293:788?798,2000","journal-title":"J Pharmacol Exp Ther"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/bbrc.1996.0208","volume":"219","author":"PJ Brent","year":"1996","unstructured":"Brent PJ, Pang G, Little G, Dosen PJ, Van Helden DF:The sigma receptor ligand,reduced haloperidol,induces apop-tosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells.Biochem Biophys Res Commun 219:219?226,1996","journal-title":"Biochem Biophys Res Commun"},{"key":"CR12","first-page":"313","volume":"62","author":"KW Crawford","year":"2002","unstructured":"Crawford KW, Bowen WD:Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineo-plastic drugs in breast tumor cell lines.Cancer Res 62:313?322,2002","journal-title":"Cancer Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0922-4106(93)90029-9","volume":"244","author":"BJ Vilner","year":"1993","unstructured":"Vilner BJ, Bowen WD:Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture.Eur J Pharmacol 244:199?201,1993","journal-title":"Eur J Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0031-6865(99)00034-5","volume":"74","author":"WD Bowen","year":"2000","unstructured":"Bowen WD:Sigma receptors:recent advances and new clinical potentials.Pharm Acta Helv 74:211?218,2000","journal-title":"Pharm Acta Helv"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","volume":"268","author":"SB Hellewell","year":"1994","unstructured":"Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD:Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors:characterization by ligand binding and photoanity labeling.Eur J Pharmacol 268: 9?18,1994","journal-title":"Eur J Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/endo-124-3-1160","volume":"124","author":"SA Wolfe Jr.","year":"1989","unstructured":"Wolfe SA,Jr., Culp SG, De Souza EB:Sigma-receptors in endocrine organs:identification,characterization,and autoradiographic localization in rat pituitary,adrenal, testis,and ovary.Endocrinology 124:1160?1172,1989","journal-title":"Endocrinology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0014-2999(89)90274-4","volume":"164","author":"ZW Yang","year":"1989","unstructured":"Yang ZW, Paleos GA, Byrd JC:Expression of (+)-3-PPP binding sites in the PC12 pheochromocytoma cell line.Eur J Pharmacol 164:607?610,1989","journal-title":"Eur J Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1523\/JNEUROSCI.15-01-00117.1995","volume":"15","author":"BJ Vilner","year":"1995","unstructured":"Vilner BJ, de Costa BR, Bowen WD:Cytotoxic effects of sigma ligands:sigma receptor-mediated alterations in cellu-lar morphology and viability.J Neurosci 15:117?134, 1995","journal-title":"J Neurosci"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1054\/bjoc.2000.1162","volume":"82","author":"J Simony-Lafontaine","year":"2000","unstructured":"Simony-Lafontaine J, Esslimani M, Bribes E, Gourgou S, Lequeux N, Lavail R, Grenier J, Kramar A, Casellas P: Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relation-ship with a series of prognostic factors.Br J Cancer 82: 1958?1966,2000","journal-title":"Br J Cancer"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P:Quantitative analysis of dose?effect relationships:the combined effects of multiple drugs or enzyme inhibitors.Adv Enzyme Regul 22:27?55, 1984","journal-title":"Adv Enzyme Regul"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.bjc.6600709","volume":"88","author":"Y Berthois","year":"2003","unstructured":"Berthois Y, Bourrie B, Galiegue S, Vidal H, Carayon P, Martin PM, Casellas P:SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo.Br J Cancer 88:438?446,2003","journal-title":"Br J Cancer"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(95)00115-2","volume":"278","author":"PJ Brent","year":"1995","unstructured":"Brent PJ, Pang GT:Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture.Eur J Pharmacol 278:151?160,1995","journal-title":"Eur J Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0024-3205(00)00523-3","volume":"66","author":"TW Moody","year":"2000","unstructured":"Moody TW, Leyton J, John C:Sigma ligands inhibit the growth of small cell lung cancer cells.Life Sci 66:1979?1986,2000","journal-title":"Life Sci"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-004-6590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-004-6590-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-004-6590-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:29:24Z","timestamp":1559233764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-004-6590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["5276590"],"URL":"https:\/\/doi.org\/10.1007\/s10549-004-6590-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}